46 phd-rehabilitation-engineering-computer-science Fellowship positions at University of Birmingham
Sort by
Refine Your Search
-
Job Description Position Details Department of Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health Location: University of Birmingham, Edgbaston, Birmingham UK
-
Job Description Position Details School of Geography, Earth and Environmental Sciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally in the range
-
Sciences, University of Birmingham, led by Dr Rebecca Drummond. We are looking for an enthusiastic and committed scientist to join our project team, which is aiming to better understand the in-host behaviour
-
Sciences, University of Birmingham, led by Dr Rebecca Drummond. We are looking for an enthusiastic and committed scientist to join our project team, which is aiming to better understand the in-host behaviour
-
for publication, research seminars etc Supervise students on research related work and provide guidance to PhD students where appropriate to the discipline Contribute to developing new models, techniques and
-
Summary Work within the PRE-EMPT programme grant and its team of co-applicants Operate within area of specialism (implementation science/behaviour change/maternal health) Analyse and interpret data and
-
and provide guidance to PhD students where appropriate to the discipline Contribute to developing new models, techniques and methods Undertake management/administration arising from research Contribute
-
are required to hold the following qualifications: A Bachelors or Masters degree, ideally in a relevant STEM discipline (eg. Biological sciences). A PhD (or near to completion) in a field relevant to the project
-
strive to integrate structural biology with functional studies in cells and whole organisms, as well as with drug design and molecular engineering. If you are curious, motivated and ready for challenge
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor